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Abstract
Background: While there is a robust literature on environmental exposure to iodine-131 (131I) in childhood and ado‑
lescence and the risk of thyroid cancer and benign nodules, little is known about its effects on thyroid volume.
Methods: To assess the effect of 131I dose to the thyroid on the volume of the thyroid gland, we examined the data
from the baseline screening of the Belarusian-American Cohort Study of residents of Belarus who were exposed to
the Chernobyl fallout at ages ≤18 years. Thyroid dose estimates were based on individual thyroid activity measure‑
ments made shortly after the accident and dosimetric data from questionnaires obtained 10-15 years later at baseline
screening. During baseline screening, thyroid gland volume was assessed from thyroid ultrasound measurements. The
association between radiation dose and thyroid volume was modeled using linear regression where radiation dose
was expressed with power terms to address non-linearity. The model was adjusted for attained age, sex, and place of
residence, and their modifying effects were examined.
Results: The analysis was based on 10,703 subjects. We found a statistically significant positive association between
radiation dose and thyroid volume (P < 0.001). Heterogeneity of association was observed by attained age (P < 0.001)
with statistically significant association remaining only in the subgroup of ≥18 years at screening (P < 0.001). For this
group, increase in dose from 0.0005 to 0.15 Gy was associated with a 1.27 ml (95% CI: 0.46, 2.07) increase in thyroid
volume. The estimated effect did not change with increasing doses above 0.15 Gy.
Conclusions: This is the first study to examine the association between 131I dose to the thyroid gland and thyroid
volume in a population of individuals exposed during childhood and systematically screened 10-15 years later. It
provides evidence for a moderate statistically significant increase in thyroid volume among those who were ≥ 18 years
at screening. Given that this effect was observed at very low doses and was restricted to a narrow dose range, further
studies are necessary to better understand the effect.
Keywords: Chernobyl nuclear accident, Radioactive iodine, Radiation, Thyroid gland, Thyroid volume, Thyroid
pathology, Dose-response relationship, Environmental exposure
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Background
Risks associated with radioactive iodine are a public
health concern both because of its widespread clinical
application for treatment of thyroid conditions and the
fact that it is preferentially absorbed and accumulated by
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the thyroid after nuclear facility accidents [1]. The accident at the Chernobyl nuclear power plant in Ukraine
in 1986 resulted in the exposure of a large population
to high doses of radionuclides, primarily 131I. It raised
concerns about the increased risk of thyroid pathologies
in children whose growing thyroid is particularly sensitive to this kind of exposure [2, 3]. Findings from two
cohorts of children residing in the contaminated territories of Belarus and Ukraine at the time of the accident
and screened for thyroid pathologies at least every 2 years
demonstrated a dose-response association between 131I
thyroid dose and thyroid cancer and follicular adenoma,
and also presented evidence of increased risk of hypothyroidism [4–10]. However, little is known about the effects
of 131I thyroid dose on thyroid volume enlargement
which could reflect a transitional state that may progress
to overt forms of thyroid diseases (e.g., diffuse or nodular
goiter).
To our knowledge, no studies have examined the doseresponse association between 131I thyroid dose and thyroid volume. Increased thyroid volume is an essential
part of simple nontoxic goiter or diffuse goiter diagnoses,
and several studies examined the risk of these conditions
after exposure to radioiodine. However, the majority of
these studies lacked individual measurements of dose
to thyroid [11–16], and the few studies that had thyroid
dose measurements had contradictory findings [17, 18].
Understanding the dose-response relationship between
131
I exposure and thyroid volume will inform clinical
decisions and public health interventions targeted at
individuals exposed to radioactive iodine as a result of
occupational exposure, medical treatment, or nuclear
fallout.
Two parallel screening cohort studies of children
exposed to the fallout from Chernobyl were established in
Belarus and Ukraine to examine associated health risks.
Standardized approach was used in screening of these
two cohorts that included ultrasound measurements for
all subjects. In this study we assessed the long-term effect
of exposure to 131I after the Chernobyl accident on the
volume of the thyroid gland 10-15 years later by examining baseline data from the cohort in Belarus.

Methods
Study subjects

We used baseline data from the Belarusian-American
Cohort Study (referred to as the “BelAm” further in the
text) conducted by the Chornobyl Thyroid Diseases
Study Group of Belarus, Ukraine, and the USA and
funded by the U.S. National Cancer Institute. A detailed
description of the BelAm study population and methods
is provided elsewhere [4, 19]. Briefly, the source population of the BelAm cohort included individuals who were
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born between April 26, 1968 and April 25, 1986, resided
in Belarus at the time of the accident, and had their 131I
thyroid activity measured in 1986 within 2 months after
the accident. Out of 38,543 records in the dose file for the
source population, 16,213 individuals, who were eligible
for the study and who could be traced, were contacted.
Among these eligible individuals, 11,970 were medically
examined at the baseline screening in 1996-2004 (11,903
in 1996-2001, 67 in 2002-2004). Baseline screening
included collection of blood and urine samples, thyroid
palpation, ultrasound examination, collection of medical
history, dosimetry interview, and fine-needle aspiration
upon reference [19].
Later, 238 records were excluded due to incorrect identification (n = 9), out of range age (n = 114), and inadequate thyroid dose estimate (n = 115), thus leaving 11,732
records available for analysis. For the purposes of this
study, we excluded a few additional categories of individuals: (1) those whose thyroid volume was not measured
at the baseline screening (n = 163); (2) those who had a
confirmed thyroid cancer, nodular goiter, thyroid surgery,
or aplasia (n = 703); (3) those who had doses over 5 Gy
(n = 161); (4) and those with extreme values of thyroid
volume (over 80 ml, n = 2). Diagnoses of thyroid cancer
and nodular goiter were confirmed via fine-needle aspiration biopsy. Individuals with thyroid cancer, nodular
goiter, thyroid surgery, or aplasia were excluded because
thyroid volume could be increased from these conditions. Individuals with doses over 5 Gy were excluded
as outliers. As a result, the analytical sample comprised
10,703 individuals.
This study was exempted from the institutional review
board of the University of California, San Francisco since
it only used existing de-identified data. The original
BelAm cohort study was approved by institutional review
boards in Belarus and the United States. Informed consent was provided by the study participants or by accompanying guardians for minors.
Measures

Thyroid volume was assessed for all participants at baseline screening via ultrasound examination. It was carried
out by physicians with special training and expertise in
thyroid ultrasonography. Thyroid gland volume was automatically calculated on the basis of its three dimensions
(length, width, depth) and measured in ml based on the
volume of an ellipsoid (length x width x depth × 0.479)
[20]. All participating personnel were blinded to the subjects’ individual radiation dose.
Individual dose of 131I to the thyroid gland, which represented about 92% of the thyroid dose [21] and came
mainly from the consumption of contaminated milk, was
measured in mGy and reconstructed from three sources:
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(1) estimated 131I activity in the thyroid derived from
direct thyroid measurements of each cohort member
that were obtained in April-June 1986, (2) application of
the radioecological model used to account for temporal
variation of 131I intake, (3) interview data on dietary and
lifestyle habits (e.g. contaminated milk consumption)
obtained during screening. Parameters of the dosimetry model were updated using additional sources, such
as thyroid volume measurements done by the Sasakawa
Memorial Health Foundation [22] used to derive age-specific thyroid masses typical for the Belarusian population;
measurements of 131I in soil, grass, and cow’s milk [23]
used to verify the validity of the calculated 131I deposition
density in the settlements and to derive the parameters of
the dose reconstruction model. The arithmetic mean of
1000 individual stochastic doses due to 131I intake, calculated for each cohort member, was used in this study as
the thyroid dose from 131I [24].
Factors potentially associated with thyroid dose and
thyroid volume, such as sex, age and oblast of residence
at baseline screening (oblast is an administrative subdivision similar to a state or province), urban/rural status
of residence, spot urinary iodine concentration, dietary
intake of iodine, smoking habit, thyroid hormone levels,
and family history of thyroid pathologies, were obtained
for all participants via personal interviews and lab tests.
Age and oblast of residence were also recorded at the
time of the accident when 131I activity in thyroid was
measured.
Statistical analysis

The relationship between 131I dose to thyroid and thyroid
volume was analyzed using multivariable linear regression models. To reflect the non-linear effect of 131I dose on
thyroid volume, we considered multiple power terms in a
form: dose1/k, where k takes the values 1, 2, 4, 8, 16, 32, 64.
We used step Akaike Information Criterion [25] to determine the number of power terms for dose to be included
in the regression model. Risk factors such as sex, age and
oblast of residence at baseline screening were a priori
included in the model as covariates since their role in the
relationship between thyroid dose and thyroid pathologies
was demonstrated in previous studies of this cohort and is
justified by biological plausibility [4, 8]. Age at screening
was included in the model in a form of linear and quadratic terms to address non-linearity and centered around
the median. Oblast of residence was used as the primary
proxy indicator of iodine deficiency, which can increase
the absorbed 131I dose, modify the dose-response, and is
a strong predictor of thyroid enlargement [26–29]. Iodine
intake at the time of the accident and changes in iodine
nutrition after the accident varied by oblast [30], making it
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a useful indicator of iodine deficiency both at the time of
the accident and at screening.
Additionally, we examined other potential confounding
variables by sequentially adding them to the model and
evaluating change in the overall effect of dose and model
fit. Potential confounders include urban/rural status of
residence, smoking, usage of multivitamins, iodine supplements or iodized salt, level of urinary iodine via urinary
iodine concentration, thyroid-stimulating hormone (TSH)
level, and family history of thyroid cancer and other thyroid
pathologies. These covariates were retained in the model
if they satisfied two criteria, including improved model fit
based on the lower value of the Akaike Information Criterion and change in the overall effect of dose by more than
10%.
Effect modification by age, sex, and oblast of residence
at the time of the accident and at baseline screening was
also examined. Given the association of age with the volume of thyroid gland, the analysis was also conducted separately by age groups. The cut point at 18 years was chosen
because thyroid gland is generally considered to stop growing after that age and widely used adult thyroid volume
norms were estimated for those 18 and older [31]. To confirm this theoretical assumption, we conducted a sensitivity
analysis varying the cut point to be at age 16, 18, 20, 22, or
24, and evaluating heterogeneity in the effect of dose in the
two age subgroups. The first cutpoint to show statistically
significant heterogeneity was age 18 years old at screening.
Consequently, the volume of the thyroid gland overall and
in the two subgroups was given by the following:
Thyroid Volume = 𝛽0 + 𝛽1 D + 𝛽2 D1∕2 + 𝛽3 D1∕4 + 𝛽4 M + 𝛽5 O1 + 𝛽6 O2 + 𝛽7 A + 𝛽8 A2 + 𝜀,

where D denotes 131I dose to thyroid gland, M denotes
gender male (female is a reference), O1 and O2 denote
oblasts of residence at screening (three categories, Minsk
is a reference, Gomel, and Other are O1 and O2 correspondingly), A1 denotes age at screening centered
around the median, and ε denotes random error.
When reporting thyroid volume distribution among
study participants, common cut-offs for thyroid enlargement in iodine-sufficient regions were applied, such that
thyroid glands > 18 ml in females and > 25 ml in males were
considered enlarged [31].
STATA (version 16.1) was used for all data analyses [32].
All statistical tests were two-sided with a pre-specified type
I error rate of 0.05.

Results
The study sample consisted of 10,703 individuals, 51%
of whom were female (Table 1) and the average age at
the time of the accident was 8 years (standard deviation
(SD) = 5 years, minimum 0, maximum 18 years, data not
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shown). More than half of the study participants resided
in the closest proximity to Chernobyl, in Gomel oblast,
both at the time of the accident (73%, data not shown)
and at the time of screening (61%, Table 1). At the time of
screening, 65% of study participants (Table 1) had some
degree of iodine deficiency (defined as urinary iodine
levels < 100 mcg/L, following the WHO classification of
iodine nutrition status [33]). Thyroid dose among participants ranged from 0.0005 to 5 Gy with a mean of 0.54 Gy
(SD = 0.74 Gy) and median of 0.26 Gy (data not shown).
Thyroid volume in the study ranged from 2.8 to 56.1 ml
with a mean of 12.0 ml (SD = 4.1, 95% CI: 11.9, 12.1)
among females and from 2.6 to 59.4 ml with a mean of
13.9 ml (SD = 5.3 ml, 95% CI: 13.8, 14.1) among males.
Mean thyroid volume was significantly higher for males
vs. females, older vs. younger individuals, those residing in oblasts other than Minsk or Gomel, and having
lower urinary iodine concentration. (Table 1). There
were 395 females (7%) and 163 males (3%) in the study
whose thyroid volume would be considered enlarged
(over 18 ml for females and over 25 ml for males [31], data
not shown). Although the distribution of thyroid volume
was very similar in males and females who were younger
than 18 years at screening, it differed by sex in older

individuals with a fully-grown thyroid (18 years and older
at screening) (Fig. 1).
In the total sample the association between thyroid dose and thyroid volume was statistically significant (P < 0.001, Table 2). The association was not linear.
Using a power model and after adjusting for age, sex,
and oblast at screening, we observed an increase in thyroid volume in the low dose range and flattening of the
effect for doses above 0.15 Gy. Predicted thyroid volume
for dose 0.15 Gy was 1.30 ml (95% CI: 0.64, 1.96) larger
than thyroid volume for dose 0.0005 Gy (lowest dose in
the cohort). This effect did not change for larger doses,
so that the predicted thyroid volume for dose 1 Gy was
1.33 ml (95% CI: 0.73, 1.93) larger than the thyroid volume for dose 0.0005 (Table 2). When we included observations with doses 5-39 Gy in the analysis, we observed
an attenuation of effect (data not shown). Although our
recent analysis of records for patients with high dose
estimates confirmed, with a high degree of confidence,
the reliability of thyroid doses exceeding 5 Gy [34], all
further analyses excluded these observations due to their
small number (n = 161) and the possibility that these
may be determined by completely different tissue reaction mechanisms [35].

Table 1 Characteristics of thyroid volume overall and by subgroups, Belarus, 1996-2004, total N = 10,703
Overall, n (%)

P-valuea

Thyroid volume (ml)
Mean

Median

95% CI

IQR

10,703 (100)

12.9

12.2

12.9, 13.0

5.5

Female

5472 (51)

12.0

11.4

11.9, 12.1

4.5

Male

5231 (49)

13.9

13.3

13.8, 14.1

6.2

10-17

3312 (31)

10.5

10.0

10.4, 10.6

4.4

18-33

7391 (69)

14.0

13.2

13.9, 14.1

5.5

Minsk

2973 (28)

13.1

12.3

12.9, 13.3

5.5

Gomel

6522 (61)

12.6

11.9

12.5, 12.7

5.3

 Otherb

1208 (11)

14.6

13.7

14.2, 14.9

6.5

Urban

6537 (61)

12.8

12.1

12.7, 13.0

5.8

Rural

4166 (39)

13.1

12.4

13.0, 13.3

5.4

1156 (11)

13.5

12.7

13.2, 13.8

5.9

Overall
Sex

< 0.001

Age at screening (years)

< 0.001

Oblast of residence at screening

< 0.001

Urban/rural status

0.096

Urinary iodine concentrationc (mcg/L)
< 20

0.002

20-49

2781 (26)

13.0

12.2

12.8, 13.2

5.6

50-99

2993 (28)

12.9

12.2

12.7, 13.0

5.6

≥ 100

3773 (35)

12.8

12.0

12.6, 12.9

5.4

Abbreviation: CI confidence interval, IQR interquartile range
a

P-values from the Kruskal-Wallis test

b

Includes Brest, Grodno, Mogilev, and Vitebsk oblasts

c

WHO criteria for iodine deficiency: < 20 severe, 20-49 moderate, 50-99 mild, ≥100 not deficient [33]
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Fig. 1 Distribution of thyroid volume by age and sex subgroups. IQR – interquartile range

Age at screening < 18 or ≥ 18 years was a significant modifier of the dose-response (P < 0.001, data not
shown), so further results are presented within the
two age subgroups. For those younger than 18 years at
screening, the association between thyroid dose and
thyroid volume was not statistically significant (P = 0.25,
Table 2) after adjusting for age, sex, and oblast at screening. The fitted model explained 18% of variability in
the data (R2 = 0.18). The observed effect of dose was
smaller than in the total sample and not statistically significant. But the shape of the association between dose
and thyroid volume had the same curvature as in the
total sample, such that an increase at low doses was followed by flattening of the curve at higher doses (Fig. 2).
Predicted thyroid volume for dose 0.15 Gy was 1.13 ml
(95% CI: − 0.07, 2.31) larger than thyroid volume for
dose 0.0005 Gy (lowest dose in the cohort). Predicted
thyroid volume for larger doses was of the same order
of magnitude (Table 2). In this age subgroup, in the
model adjusted for thyroid dose, thyroid volume was
significantly larger in males in comparison to females,
in Brest, Grodno, Mogilev, and Vitebsk oblasts in comparison to Minsk or Gomel oblasts, and it increased
with age (Table 2). No significant effect modification by
sex (P = 0.22, data not shown), or oblast at the time of
the accident (P = 0.75, data not shown) or at screening
(P = 0.48, data not shown) was observed within a stratum of younger than 18 years of age at screening.

For those 18 years or older at the time of screening, we observed a statistically significant association
between dose and thyroid volume (P < 0.001) after
adjusting for age, sex, and oblast at screening. The fitted model explained only 14% of variability in the data
(R2 = 0.14). The shape of the relationship followed the
same curve as in the total sample and subgroup of
< 18 years old at screening (Fig. 2). Predicted thyroid
volume for dose 0.15 Gy was 1.27 ml (95% CI: 0.46,
2.07) larger than thyroid volume for dose 0.0005 Gy
(lowest dose in the cohort). The effect was very similar
for larger doses, so that predicted thyroid volume for
dose 1 Gy was 1.38 ml (95% CI: 0.66, 2.09) larger than
the thyroid volume for dose 0.0005 (Table 2). Similar to
those < 18 years old, in the model adjusted for thyroid
dose, thyroid volume was significantly larger in males in
comparison to females and in Brest, Grodno, Mogilev,
and Vitebsk oblasts in comparison to Minsk and Gomel
oblasts (Table 2). No significant effect modification by
sex (P = 0.33, data not shown), or oblast at the time of
the accident (P = 0.23, data not shown) or at screening
(P = 0.70, data not shown) was observed within a stratum of ≥18 years of age at screening.

Discussion
This is the first analysis of baseline data from a cohort
study in Belarus to examine the association between
the dose to the thyroid gland and thyroid volume. We
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Table 2 Thyroid volume (ml) estimates with 95% confidence intervals from the linear regression models, Belarus, 1996-2001
Explanatory parameter

Thyroid volume estimates
Overall (N = 10,703)

Younger than 18 years at screening
(n = 3312)

18 years or older at screening
(n = 7391)

0.0005 Gyb

Reference

Reference

Reference

0.001 Gy

0.129 (0.050, 0.208)

0.120 (−0.016, 0.256)

0.123 (0.024, 0.222)

0.05 Gy

1.073 (0.488, 1.658)

0.956 (−0.080, 1.992)

1.035 (0.316, 1.754)

0.1 Gy

1.225 (0.584, 1.866)

1.075 (−0.073, 2.222)

1.190 (0.407, 1.972)

0.15 Gy

1.297 (0.637, 1.957)

1.125 (−0.065, 2.314)

1.266 (0.464, 2.067)

0.5 Gy

1.385 (0.742, 2.027)

1.144 (−0.041, 2.330)

1.390 (0.620, 2.159)

1 Gy

1.326 (0.728, 1.925)

1.057 (−0.053, 2.166)

1.375 (0.660, 2.089)

2 Gy

1.206 (0.614, 1.798)

0.938 (−0.126, 2.003)

1.323 (0.589, 2.056)

4 Gy

1.135 (0.234, 2.035)

0.950 (−0.435, 2.335)

1.352 (0.091, 2.612)

4.5 Gy

1.146 (0.114, 2.178)

0.990 (−0.550, 2.530)

1.383 (−0.084, 2.851)

P < 0.001c

P = 0.247c

P < 0.001c

Female

Reference

Reference

Reference

Male

2.052 (1.892, 2.213)

0.369 (0.120, 0.617)

2.779 (2.578, 2.980)

P < 0.001

P = 0.004

P < 0.001

Minsk

Reference

Reference

Reference

Gomel

−1.230 (−1.444, −1.016)

− 1.094 (− 1.404, −0.784)

−1.223 (− 1.502, −0.945)

0.680 (0.385, 0.976)

0.689 (0.216, 1.162)

0.733 (0.365, 1.102)

P < 0.001

P = 0.004

P < 0.001

Group median a gee

Reference

Reference

Reference

1 year increase

0.380 (0.365, 0.396)

0.845 (0.758, 0.931)

0.235 (0.208, 0.261)

2 years increase

0.714 (0.683, 0.746)

1.495 (1.269, 1.721)

0.455 (0.401, 0.509)

5 years increase

1.437 (1.346, 1.529)

–

1.032 (0.847, 1.217)

7 years increase

1.687 (1.533, 1.840)

–

1.346 (1.012, 1.681)

P < 0.001

P < 0.001

P < 0.001

Radiationa

Sex

Oblast at screening

P < 0.001
 Otherd
Age at screening (years)

P < 0.001

P < 0.001

a

Holding all covariates at their reference values, the mean estimated thyroid volume at reference dose 0.0005 Gy (the lowest dose in the study) was 11.0 ml overall,
9.0 ml in the subgroup < 18 years, and 11.5 ml in the subgroup ≥18 years. Thyroid volume estimates at specific doses are an increase above the reference thyroid
volumes

b

Lowest dose in the study is 0.0005 Gy

c

P-value for the association between thyroid dose and thyroid volume using linear regression model with three power terms for dose (dose1/1 + dose1/2 + dose1/4)

d
e

Includes Brest, Grodno, Mogilev, and Vitebsk oblasts

Median age (reference): 21 years overall, 15 years in the subgroup < 18 years, and 24 years in the subgroup ≥18 years

found that in children exposed to the Chernobyl fallout, 10-15 years later there was a statistically significant
association between thyroid dose and increased thyroid
volume, but only among those older than 18 years of
age during screening. We observed a dose response that
increased from 0.0005 to 0.15 Gy and then flattened with
little further effect on thyroid volume at larger doses up
to 5 Gy.
The reason for the observed effect is unclear. It is possible that this association is mediated by changes in TSH

[9, 36]. According to this hypothesized biological mechanism, radiation dose to the thyroid gland could cause cell
killing and decrease in thyroid hormones that leads to
stimulation of the pituitary gland [37], and consequent
increase in thyroid gland volume [38–40]. While associations between TSH level and thyroid volume [38–40] and
between thyroid radiation dose and TSH [9, 36] are well
described, the association between thyroid radiation dose
and thyroid volume has not been previously examined.
Our study adds to the existing literature by suggesting
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Fig. 2 Association between thyroid dose due to 131I and thyroid volume at screening. Average effect of thyroid dose due to 131I on thyroid volume
at screening from a linear regression model adjusted for sex, oblast, and age at screening in the subgroup of a younger than 18 years of age at
screening; b 18 years and older at screening

a highly non-linear effect of 131I dose on increased thyroid gland volume. We observed similar non-linear doseresponse when we analyzed the association between
131
I thyroid dose and prevalent hypothyroidism (serum
TSH > 4 mIU/L) during baseline screening in this cohort
[9]. At doses < 5 Gy, there was a similar sharp increase
in odds ratio for the dose category 0.1-0.25 Gy, with no
further changes with increasing doses. A different pattern was observed in a similar cohort in Ukraine, where
a sharp increase in odds ratio for the dose category 0.10.25 Gy was followed by a linear dose-response for doses
< 5 Gy [10]. Analysis of TSH on a continuous scale was
also performed in Belarusian cohort but not in Ukrainian, and in contrast to analysis of TSH on a dichotomous
scale (i.e. hypothyroidism) it demonstrated a significant
positive dose-response with 131I for the whole range of
doses up to 5 Gy [9]. It is somewhat unlikely that increase
in thyroid volume at only the lowest doses observed in
our study reflects an actual physiological effect. Several
analyses of thyroid outcomes in this cohort observed
flattening of the dose-response at doses > 5 Gy [4, 8, 41].
Similar effects were observed in studies of atomic bomb
survivors and patients treated with radiotherapy, suggesting cell killing happening at very high doses [1, 42, 43].
However, this effect could be very different from the tissue expansion effect we examined in our study.
Our findings also shed light on the differing results
from previous studies on the effect of 131I exposure on

benign thyroid conditions, such as enlarged thyroid
or diffuse goiter. Given that the effect we observed was
highly non-linear and seen only at the lowest doses, it
could easily be overlooked when specific thresholds
for thyroid volume are applied to make the diagnosis
of enlarged thyroid or diffuse goiter. The fact that some
studies showed no effect [12, 17], while others found
a positive association between 131I exposure and diffuse goiter [13, 18] is therefore unsurprising, and may
also reflect low statistical power in some of these studies. Because our study focuses solely on thyroid volume
rather than on a diagnosis of thyroid enlargement or diffuse goiter, we were able to detect even weak signals in
the data that might otherwise be obscured.
One of the main advantages of our study is the availability of individual 131I doses to the thyroid for each participant in the cohort, which have been improved over
time to account for possible uncertainties [21, 24]. This
feature, along with a wide range of doses and the large
and diverse cohort exposed to the Chernobyl fallout,
contribute to the statistical power of this study. Another
advantage is that thyroid volumes were measured for all
study participants regardless of clinical presentation and
according to a standardized protocol.
Some possible limitations of this study should be noted.
One of them is that screening, including thyroid volume measurement, was conducted at least 10 years after
the exposure. Missing data on dietary iodine during this
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period could lead to residual confounding from using
proxy indicators of iodine nutrition status. As shown in
previous studies, iodine deficiency could play an important role in the relationship between 131I dose to thyroid
and pathologies closely related to thyroid volume, such
as diffuse goiter [11, 26, 27, 30]. A negative association
between urinary iodine excretion levels and prevalence
of goiter was observed in several studies [11, 30]. There
is also literature suggesting an increase in the absorbed
131
I thyroid dose in iodine-deficient individuals [26–28].
Thus, having a proper measurement of iodine nutrition
status on an individual level is important for estimating
the direct effect of 131I dose. Since urinary iodine concentration at one time point is not an adequate measure of
individual iodine status [44], we used oblast of residence
as the primary proxy indicator of iodine nutrition status.
Epidemiological studies and surveys of stable iodine in
soil in settlement at the time of the accident demonstrate
that iodine nutrition varied by oblast, thus making it a
useful indicator of iodine deficiency [29, 30]. Although
iodine deficiency is thought to increase 131I uptake by the
thyroid gland [26], in our study we did not observe effect
modification of dose by either oblast at the time of the
accident, or at screening.
The fact that approximately 30% of the study population were under the age of 18 years at the time of screening and likely did not have a fully grown thyroid limits
our ability to make inferences about this age subgroup.
This issue is partially addressed by presenting stratumspecific effect estimates. Analyses using the data from
the next screening cycles of the cohort should be able to
address this limitation.
Since only 31% (11,918 of 38,543) of the source population participated in the BelAm study because of problems
with tracing (n = 20,526), eligibility (n = 1804), or nonresponse (n = 4295) there is a potential for selection bias.
There appeared to be a greater proportion of individuals from more severely contaminated areas and younger
children (0-9 years old) in the cohort in comparison to
the source population of individuals who were selected
for tracing and recruitment to the study [19]. However,
it is unlikely that individuals were selected differentially based on both dose and thyroid volume. Also, the
study provides data on a large range of 131I thyroid doses
(0.0005-5 Gy) and thyroid volumes (2.6-59.4 ml).
Given the unexpected non-linearity in radiation effect
on the thyroid volume observed at the lowest doses for
those ≥18 years old at screening, potential measurement errors should be considered. However, ultrasound
measurements of thyroid volume were done by physicians with special training in ultrasound sonography who
were blinded to the subjects’ individual radiation dose.
The current study uses individual doses that are based on
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means of 1000 Monte Carlo simulations which take into
account a number of uncertainties from the dose model.
Therefore, potential systematic measurement errors, if
any, were minimized.

Conclusions
In summary, this is the first study to examine association between 131I dose to the thyroid gland and thyroid
volume in a population of individuals exposed during
childhood and systematically screened 10-15 years later.
Previous studies had much more limited information on
thyroid volume [18] or dose [11–15]. Our study adds to
the current literature by providing evidence for a moderate statistically significant increase in thyroid volume
among those who were 18 years or older 10-15 years after
the accident. This increase in thyroid volume occurs
only at very low 131I doses (0.0005-0.15 Gy), and volume
does not show any further change with increasing radiation dose up to 5 Gy. Although it could be hypothesized
that this effect is mediated by TSH levels, the established
knowledge on the cell killing that occurs at much higher
131
I doses prevents us from stating a clear biologic mechanism of the observed effect. Replication of this analysis
using the data from the parallel study in Ukraine would
help to better understand these findings. Extended follow-up is necessary to determine whether thyroid gland
growth continues beyond the first 10-15 years after exposure. Since only part of this cohort was 18 years or older
at the time of baseline screening, analysis of data from
future screening cycles is needed to shed more light on
whether there are any radiation effects on thyroid volume
among those exposed at young ages.
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